NASDAQ:AMGN
Amgen Inc. Stock News
$269.98
+0.600 (+0.223%)
At Close: Apr 26, 2024
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
02:59am, Wednesday, 14'th Feb 2024
Amgen is the latest big pharma to join the gold rush to treat obesity. Its candidate is distinct from the medicines by Eli Lilly and Novo Nordisk.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Monday, 12'th Feb 2024
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
04:00pm, Friday, 09'th Feb 2024
THOUSAND OAKS, Calif. , Feb. 9, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 34th Annual Oppenheimer Healthcare Life Sciences Conference at 12:00 p.m.
PBYI vs. AMGN: Which Stock Should Value Investors Buy Now?
12:40pm, Friday, 09'th Feb 2024
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Puma Biotech (PBYI) and Amgen (AMGN). But which of these two stocks offers value investors a better
Amgen has 'a lot to prove' in the weight-loss drug category, says Mizuho's Jared Holz
06:24pm, Thursday, 08'th Feb 2024
Jared Holz, Mizuho, joins 'Closing Bell Overtime' to talk Amgen's obesity drug trial results.
Amgen (AMGN) Q4 Earnings Top, Horizon Drugs Drive Sales
10:56am, Wednesday, 07'th Feb 2024
Amgen (AMGN) beats fourth-quarter estimates for earnings and sales. Horizon's products add $954 million in sales in the quarter.
Amgen Inc. (AMGN) Q4 2023 Earnings Call Transcript
10:40pm, Tuesday, 06'th Feb 2024
Amgen Inc. (AMGN) Q4 2023 Earnings Call Transcript
Amgen (AMGN) Reports Q4 Earnings: What Key Metrics Have to Say
09:01pm, Tuesday, 06'th Feb 2024
Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street
Amgen (AMGN) Q4 Earnings and Revenues Top Estimates
06:11pm, Tuesday, 06'th Feb 2024
Amgen (AMGN) came out with quarterly earnings of $4.71 per share, beating the Zacks Consensus Estimate of $4.66 per share. This compares to earnings of $4.09 per share a year ago.
Amgen's quarterly results top expectations despite Enbrel sales decline
04:43pm, Tuesday, 06'th Feb 2024
Amgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts' expectations even as revenues dropped for one of its top sellers, the rheumatoid-arthritis drug Enbrel.
Amgen Dips Despite Beating Fourth-Quarter Sales Expectations
04:16pm, Tuesday, 06'th Feb 2024
Amgen stock dipped late Tuesday after the company beat fourth-quarter sales expectations, noting nine products hit records.
Amgen quarterly profit rises 15% as Horizon deal boosts results
04:05pm, Tuesday, 06'th Feb 2024
Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Thera
Focus: Amgen taking different path to weight loss windfall
06:03am, Tuesday, 06'th Feb 2024
The popularity of a new generation of weight-loss medicines is inspiring a growing number of drugmakers to pursue paths emulating Eli Lilly's highly-effective Zepbound, but Amgen is taking a unique ap
3 Fantastic Dow Stocks to Buy in February 2024
11:05pm, Monday, 05'th Feb 2024
While the Nasdaq exchange and S&P 500 grabbed the headlines because of the massive run-up by the so-called Magnificent 7 stocks, the Dow Jones Industrial Average plodded on with its Dow stocks to buy.
Promising early data details on Amgen weight-loss drug published
05:04am, Monday, 05'th Feb 2024
Animal and early-stage human trial data for Amgen's experimental obesity drug published in a medical journal showed that it promoted significant weight loss with an acceptable safety profile, the comp